Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Mid-range Performer
19315.0000 260.00 (1.36%)
NSE Oct 27, 2026 15:31 PM
Volume: 22,944
 

19315.00
1.36%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Promoters pledged 0.03% of shares in last quarter. Total pledge stands at 2.32% of promoter holdings
More from Neuland Laboratories Ltd.
Recommended